(S)-2-(((9H-Fluoren-9-yl-methoxy)carbonylamino)-3-methylbutanamido)-5-ureidopentanoic Acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (S)-2-(((9H-Fluoren-9-yl-methoxy)carbonylamino)-3-methylbutanamido)-5-ureidopentanoic Acid
• 英文别名: Fmoc-DL-Val-Cit-OH；(2S)-5-(carbamoylamino)-2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoyl]amino]pentanoic acid
• 化学式: C₂₆H₃₂N₄O₆
• 分子量: 496.563
• InChiKey: ZJLNQOIFTYLCHC-HMTLIYDFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  36
• 可旋转键数：
  12
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  160
• 氢给体数：
  5
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  (S)-2-(((9H-Fluoren-9-yl-methoxy)carbonylamino)-3-methylbutanamido)-5-ureidopentanoic Acid 在 2-乙氧基-1-乙氧碳酰基-1,2-二氢喹啉 、 二乙胺 、 N,N-二异丙基乙胺 、 sodium hydroxide 作用下， 以 N-甲基吡咯烷酮 、 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成
  参考文献：
  名称：

  Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cure

  摘要：

  DOI：

  10.1016/j.jconrel.2020.12.046
• 作为产物：
  描述：

  Fmoc-valine 在 碳酸氢钠 、 N,N'-二环己基碳二亚胺 作用下， 以 四氢呋喃 、 乙二醇二甲醚 、 二氯甲烷 、 水 为溶剂， 生成 (S)-2-(((9H-Fluoren-9-yl-methoxy)carbonylamino)-3-methylbutanamido)-5-ureidopentanoic Acid
  参考文献：
  名称：

  Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cure

  摘要：

  DOI：

  10.1016/j.jconrel.2020.12.046

文献信息

• [EN] CONJUGATES FOR TREATING DISEASES<br/>[FR] CONJUGUÉS POUR LE TRAITEMENT DE MALADIES
  申请人：ENDOCYTE INC

  公开号：WO2016148674A1

  公开（公告）日：2016-09-22

  The present disclosure relates to pyrrolobenzodiazepine (PBD) prodrugs and conjugates thereof. The present disclosure also relates to pharmaceutical compositions of the conjugates described herein, methods of making and methods of using the same.

  本公开涉及吡咯苯并二氮杂环（PBD）前药及其结合物。本公开还涉及所述结合物的药物组合物，制备方法和使用方法。
• Process for the conjugation of a peptide or protein with a reagent comprising a leaving group including a portion of PEG
  申请人：POLYTHERICS LIMITED

  公开号：US10835616B2

  公开（公告）日：2020-11-17

  The invention relates to novel conjugating reagents capable of reaction with at least one nucleophile present in a peptide or protein, which contain at least one leaving group which is lost on reaction with said nucleophile, in which the leaving group includes a portion —(CH2CH2O)n—, in which n is a number of six or more; and novel processes for the preparation of conjugates containing peptides or proteins made using such reagents.

  本发明涉及能够与肽或蛋白质中存在的至少一个亲核物反应的新型共轭试剂，该试剂含有至少一个在与所述亲核物反应时失去的离去基团，其中离去基团包括-(CH2CH2O)n-部分，其中n为6或6以上的数字；以及使用此类试剂制备含有肽或蛋白质的共轭物的新型工艺。
• Conjugates And Conjugating Reagents
  申请人：POLYTHERICS LIMITED

  公开号：US20170290925A1

  公开（公告）日：2017-10-12

  The invention relates to a conjugate of a protein or peptide with a therapeutic, diagnostic or labelling agent, said conjugate containing a protein or peptide bonding portion and a polyethylene glycol portion; in which said protein or peptide bonding portion has the general formula: in which Pr represents said protein or peptide, each Nu represents a nucleophile present in or attached to the protein or peptide, each of A and B independently represents a C 1-4 alkylene or alkenylene chain, and W′ represents an electron withdrawing group or a group obtained by reduction of an electron withdrawing group; and in which said polyethylene glycol portion is or includes a pendant polyethylene glycol chain which has a terminal end group of formula —CH 2 CH 2 OR in which R represents a hydrogen atom, an alkyl group, or an optionally substituted aryl group. Also claimed are a method for making such a conjugate, and novel reagents useful in that method.
• Process For The Conjugation Of A Peptide Or Protein With A Reagent Comprising A Leaving Group Including A Portion Of PEG
  申请人：POLYTHERICS LIMITED

  公开号：US20170304461A1

  公开（公告）日：2017-10-26

  The invention relates to novel conjugating reagents capable of reaction with at least one nucleophile present in a peptide or protein, which contain at least one leaving group which is lost on reaction with said nucleophile, in which the leaving group includes a portion —(CH 2 CH 2 O) n —, in which n is a number of six or more; and novel processes for the preparation of conjugates containing peptides or proteins made using such reagents.
• [EN] NOVEL CONJUGATES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF<br/>[FR] NOUVEAUX CONJUGUES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
  申请人：SANOFI AVENTIS

  公开号：WO2011001052A1

  公开（公告）日：2011-01-06

  L'invention est relative à un agent de ciblage auquel est attaché au moins un dérivé de cryptophycine de formule (I) : dans laquelle : R1 représente un atome d'halogène et R2 représente un groupe -OH, un groupe acyle dérivé d'un acide aminé AA ou un groupe (C1-C4)alcanoyloxy; ou bien R1 et R2 forment ensemble un motif époxyde; AA désigne un acide aminé naturel ou non-naturel; R3 représente un groupe (C1-C6)alkyle; R4 et R5 représentent tous deux H ou forment ensemble une double liaison CH=CH entre C13 et C14; R6 et R7 représentent indépendamment l'un de l'autre H ou un groupe (C1-C6)Jalkyle; R8 et R9 représentent indépendamment l'un de l'autre H ou un groupe (C1-C6)alkyle; R10 représente au moins un substituant du noyau phényle choisi parmi : H, un groupe OH, (C1-C4)alcoxy, un atome d'halogène ou bien un groupe -NH2, -NH(C1-C6)alkyle ou -N(C1- C6)alkyle2; R11 représente au moins un substituant du noyau phényle choisi parmi H ou un groupe (C1- C4)alkyle; l'agent de ciblage et le dérivé de cryptophycine étant attachés de façon covalente, l'attachement se situant en position ortho (o), meta (m) ou para (p) du noyau phényle porteur du motif CR1.